1-02-2023, 18:39

Cerevel Therapeutics to Report Fourth Quarter and Full Year

CAMBRIDGE, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to
Globe Newswire1-02-2023, 18:39